Objectives: Drug resistance in parasitic protozoa is an obstacle to successful chemotherapy. Understanding how pathogens respond to drugs is crucial in preventing resistance. Previously, we have shown that in Entamoeba histolytica, methionine g-lyase (EhMGL) downregulation results in trifluoromethionine resistance. The transcriptional response, however, of this parasite to the drug is not known. In this study, we used microarray analysis to determine whether additional genes are involved.
Introduction
Parasitic diseases in man can be controlled, at least in part, by chemotherapeutic drugs. How long this situation will last, however, is a matter for conjecture since drug resistance is becoming an increasing problem. 1 -4 Drug resistance occurs in parasitic protozoans by various mechanisms; 5 -10 in Entamoeba histolytica, the causative agent of amoebic dysentery and liver abscess, 11 in vitro studies with emetine and metronidazole have led to the recognition of some basic mechanisms by which E. histolytica becomes resistant to these drugs. 6 -10 A common mechanism is the efflux system where toxic substances are extruded through specific pumps. 9, 10, 12 This mechanism is thought to be operative in E. histolytica resistant to emetine, where multiple P-glycoprotein genes encoding putative transmembrane channels were shown to have increased expression. 9, 10 Metronidazole resistance, on the other hand, has been associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin, and decreased expression of flavin reductase and ferredoxin 1. 6 -8 Currently, metronidazole is still the drug of choice against amoebic infections, 13 but in the event that clinical resistance to this drug becomes prevalent, the lack of an alternative drug would cause major health problems in endemic areas.
Trifluoromethionine (S-trifluoromethyl-L-homocysteine) is a halogenated methionine analogue, previously reported to exert antimicrobial activity against anaerobic bacteria and parasitic protozoa such as E. histolytica and Trichomonas vaginalis. 14 -18 Inside the cell, trifluoromethionine is catabolized by methionine g-lyase (EC 4.4.1.11, EhMGL1/2) into a-keto butyrate, ammonia and trifluoromethanethiol. The last product is unstable under physiological conditions and non-enzymatically converted to carbonothionic difluoride, a potent cross-linker of primary amine groups, by which trifluoromethionine exerts it toxic effects. 17 In 2010, Sato et al., 14 reported the superior cytotoxic effect of trifluoromethionine compared with metronidazole, and that a single administration of trifluoromethionine effectively prevented the formation of amoebic liver abscess in a rodent model. Previously, however, we reported that E. histolytica has the capacity to develop resistance against the drug in vitro, and that resistance was associated with EhMGL repression. 19 DNA microarray technology is a powerful tool that can probe the genome on high-density microarrays and analyse the expression profiles of thousands of genes simultaneously. 20 -22 To further understand the nature of resistance to trifluoromethionine, we used cDNA microarray technology to examine the mRNA expression of trifluoromethionine-resistant (TFMR) isogenic strains. We compared the results with the transcriptome of TFMR cells cultured in the absence of the drug, with strains targeted for EhMGL gene silencing, those selected for metronidazole resistance and those cultured in cysteine-deprived medium; we observed the specific regulation of a set of genes that may represent a signature profile of trifluoromethionine resistance.
Materials and methods

Chemicals, reagents, and drugs
Trifluoromethionine was produced as described previously. 14, 15 Metronidazole, L-cysteine, anti-HA-agarose and E-64 (transepoxysuccinyl-L-leucylamido- [4-guanidino] butane) were purchased from Sigma-Aldrich (St. Louis, MO, USA). TRIzol Reagent, SuperScript III FirstStrand Synthesis System, PLUS reagent, Lipofectamine and geneticin (G418) were acquired from Invitrogen (Carlsbad, CA, USA). All other chemicals were obtained from Wako Pure Chemical (Osaka, Japan) unless otherwise stated. Trifluoromethionine and metronidazole were dissolved in DMSO to a stock concentration of 200 mM and 100 mM, respectively, and stored at 2308C.
Parasites and cultivation
E. histolytica strains HM-1:IMSS cl6 (HM-1) and G3, kindly given by David Mirelman, Weisman Institute, Israel, were cultured axenically in BI-S-33 medium for 48-72 h at 35.58C in 13 mm×100 mm Pyrex screw cap culture tubes or 25 cm 2 tissue culture flasks (#152094, Nunc, Roskilde, Denmark). 23 Generation and cultivation of TFMR in the presence or absence of trifluoromethionine (EhMGL1gs and EhMGL2gs) were as previously described. 19 Isogenic cells with reduced susceptibility to 8 mM metronidazole were selected following the method outlined by Wassmann et al. 7 Trophozoites grown under cysteine-deprived conditions were cultured in BI-S-33 medium without 8 mM L-cysteine supplementation for 24 h as previously described. 24 
RNA isolation
Cells cultured in 25 cm 2 tissue culture flasks were harvested by replacing the spent medium with 10 mL of PBS, pH 7.2, followed by incubation on ice for 10 min. Cell suspension was centrifuged at 500×g for 5 min at 48C and the pellet washed thrice with PBS. Total RNA was extracted with TRIzol Reagent according to the manufacturer's instructions, cleaned with an RNeasy kit (Qiagen, Germany) and assessed for quality with the Experion automated electrophoresis system and Experion RNA StdSens analysis kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA). RNA quantity was determined by measuring the absorbance at 260 nm with a NanoDrop ND-1000 UV-Vis spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA).
Microarray hybridization
Samples from three independent RNA extractions were processed according to standard protocols and by using kits specified in the Affymetrix GeneChip Expression Analysis Technical Manual (P/N 702232 Rev. 3). 25 Briefly, 5 mg of RNA was reverse transcribed to cDNA and used to synthesize biotin-labelled cRNA. After purification, cRNA was fragmented and hybridized onto a probe array chip (Eh_Eia520620F) that was custom made by Affymetrix (Santa Clara, CA, USA). 24, 26 Following hybridization, arrays were washed and stained with streptavidin/phycoerythrin (Molecular Probes, Eugene, OR, USA) using an Affymetrix GeneChip Fluidics Station 450. Arrays were scanned with an Affymetrix GeneChip Scanner 3000 at 570 nm. Each array image was visually screened to discard signal artifacts, scratches and debris.
The microarray used in this study was tailored based on information mined from the E. histolytica and Entamoeba invadens sequences stored at the TIGR and Pathema databases. It contained 9230 probe sets for E. histolytica and an additional 25 and 81 control probe sets for Entamoeba and Affymetrix, respectively. Nomenclature for the IDs was based on whether the probe set is unique to either TIGR (e.g. 12.m00345) or Pathema (EHI_123456), or is found in both databases (98.m00765_234567). Probe sets labelled with '_at' represent a single gene, while those labelled '_s_at' represent probe sets that share all probes identically with at least two sequences. The '_s_at' probe sets represent highly similar transcripts, shorter forms of alternatively polyadenylated transcripts, or common regions in the 3 ′ ends of multiple alternative splice forms. Probe sets labeled '_x_at', on the other hand, represent probe sets where it was not possible to select either a unique probe set or a probe set with identical probes among multiple transcripts. Rules for cross-hybridization were excluded in order to design '_x_at' probe sets, therefore these probe sets could cross-hybridize with other genes in an unpredictable manner. 27 
Data normalization and analysis
Raw probe intensities were generated by the GeneChip Operating Software (GCOS) and a GeneTitan Instrument. The resulting expression values were analysed by Genespring GX 10.0.2 to identify differentially expressed genes. Only genes that were considered 'present' by GCOS in at least two arrays were used in further analysis. Correlation coefficients were calculated in Genespring using standard correlation. Probe sets were considered differentially expressed between HM-1 and TFMR if they had at least a 3-fold change and P value ,0.05, calculated using Welch's t-test, after multiple test correction by the BenjaminiHochberg method. A post-hoc test using Tukey's Honestly Significant Difference test was conducted to determine significant differences between samples.
Deduced amino acid sequences of differentially expressed genes were searched against GenBank by using BLAST. 28 Matches against hypothetical proteins with E-value ,10
275 for BLASTP were considered as putative Penuliar et al.
orthologues. 29 GO annotations were mined from the Gene Ontology Annotation Database, 30 while the genomic location of each gene was obtained from Pathema-Entamoeba. 31 Transmembrane domain prediction was performed using the following online servers: HMMTOP, 32 SOSUI, 33 TMHMM, 34 TopPred, 35 TMpred 36 and Phobius. 37 Signal peptide sequences were predicted using SignalP, 38 SOSUIsignal 39 and Phobius. 37 Putative transmembrane domains and signal peptides were considered valid only if positive hits were found in all servers used. Heatmaps were made using Heatmap Builder 40 while Venn diagrams were constructed using Venn Diagram Generator. 41 
Data deposition
The microarray data reported in this paper has been deposited in the Gene Expression Omnibus (GEO) database 42 with accession number GSE32314.
Quantitative real-time PCR (qRT-PCR)
Total RNA extracted for the microarray was used for qRT-PCR. The synthesis of cDNA was performed using the SuperScript III First-Strand Synthesis System according to the manufacturer's instructions. The cDNA synthesis was completed on a DNA Engine Peltier Thermal Cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The Fast SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA) was used for qRT-PCR in accordance with the manufacturer's instructions. The list of genes whose expression was verified by qRT-PCR is in Table S1 , and includes a housekeeping gene, RNA polymerase II (EhRNAPII), as a control. Each PCR reaction contained 5 mL (1:50 dilution) of cDNA and 15 mL of primer mix, composed of 10 mL of 2× Fast SYBR Green Master Mix, sense and antisense primers and nuclease-free water, to bring the volume to 20 mL. qRT-PCR was performed using a StepOne Plus RealTime PCR System (Applied Biosystems, Foster City, CA, USA) with the following cycling conditions: enzyme activation at 958C for 20 s, followed by 40 cycles of denaturation at 958C for 3 s and annealing/extension at 608C for 30 s. All test samples were run in triplicate including an RT-negative control for each sample set along with a blank control consisting of nuclease-free water in place of cDNA. Quantification for each target gene was determined by the DDCt method with EhRNAPII as the reference gene.
Generation of transgenic amoeba overexpressing EhBspA1
Full-length EhBspA1 was amplified from TFMR cDNA with sense and antisense primers containing appropriate restriction sites (Table S1 ). After purification the gene was inserted into an expression plasmid, pEhEx, as previously described. 43 The plasmid was introduced into the G3 strain by lipofection, with minor modifications as previously described. 44 Briefly, 5×10 5 cells suspended in 5 mL of supplemented Opti-MEM medium were seeded into a well in a 12-well plate and incubated under anaerobic condition at 35.58C for 30 min. Following incubation, 4.5 mL of medium from each well was removed and 500 mL of liposome/plasmid mixture (5 mg of plasmid, 10 mL of PLUS reagent and 20 mL of Lipofectamine in Opti-MEM medium) was added. After 5 h of transfection, cells were harvested by placing the plate on ice for 15 min, then added to culture tubes with 5.5 mL of cold BI-S-33 medium, and incubated at 35.58C for 24 h. Transformants were initially selected in the presence of 1 mg/mL G418 and drug concentration was gradually increased to 20 mg/mL over the following four weeks before the transformants were analysed.
Immunoblot analysis
Total protein (30 mg) was separated in 12% (w/v) SDS-polyacrylamide gel under reducing conditions and subsequently electrotransferred onto nitrocellulose membranes (Hybond-C Extra; Amersham Biosciences, Little Chalfont, Bucks, United Kingdom). Membranes were blocked by incubation in 5% non-fat dried milk (BD, Le Pnt de Claix, France) in TBST (50 mM Tris-HCl, pH 8.0, 150 mM NaCl and 0.05% Tween 20) for 1.5 h. Blots were reacted with 1 : 1000 diluted anti-HA mouse monoclonal antibody (Clone 16B12) (Covance, Berkeley, CA, USA) for 1 h. The membranes were washed with TBST and further reacted with 1 : 1000 alkaline phosphatase-conjugated anti-mouse IgG antibody (New England Biolabs, Beverly, MA, USA) for 1 h. After further washings with TBST, specific proteins were visualized with an alkaline phosphatase conjugate substrate kit (Bio-Rad, Hercules, CA, USA) and scanned with an ImageScanner (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The experiments were repeated in triplicate with protein isolated from two independent extractions.
Measurement of E. histolytica adhesion
Trophozoites in exponential growth phase were harvested, washed with cold PBS, and centrifuged at 500×g for 5 min at 48C. The plate adhesion assay was performed as previously described. 19 Briefly, approximately 1×10 5 trophozoites were seeded into a well of a 96-well plate coated with either human fibronectin (BD BioCoat Cell Environment; BD Biosciences, San Joe, CA, USA) or collagen type I (SigmaScreen; Sigma-Aldrich, St Louis, MO, USA), and incubated under anaerobic conditions using Anaerocult A (Merck, Darmstadt, Germany) for up to 40 min at 35.58C. The medium was removed and non-adherent cells were gently washed twice with PBS warmed to 35.58C. Adherent cells were fixed with 40 mg/mL paraformaldehyde (TAAB Laboratories, Aldermaston, England) for 10 min and washed twice with PBS. Cells were stained with 1 mg/mL methylene blue in 100 mM borate buffer, pH 8.7, for 20 min and washed twice with distilled water. The stain was extracted with 200 mL of 20 mg/mL SDS and the absorbance measured at 660 nm using a DU 530 Spectrophotometer (Beckman Coulter, Fullerton, CA, USA).
Immunofluorescence assay
To determine the subcellular location of EhBspA1, transfected amoebae were processed for an indirect immunofluorescence assay. Briefly, amoebae in 6 mL of confluent culture were incubated on ice for 10 min, concentrated by centrifugation at 500×g for 5 min and spotted onto an 8 mm well of a glass slide (Wheaton Science Products, Millville, NJ, USA). After incubation at 35.58C for 15 min, spent medium was removed, and cells were washed with PBS and fixed with 40 mg/ mL paraformaldehyde (TAAB Laboratories, Berks, England) for 10 min. Following a further PBS wash, cells were permeabilized and blocked with 0.2% (w/v) saponin in 1% (w/v) BSA in PBS for 10 min, and incubated with 1 : 1000 monoclonal anti-HA antibody for 1 h. After a PBS wash, cells were reacted with 1 :1000 anti-mouse IgG conjugated with Alexa Fluor 488 (Invitrogen, Carlsbad, CA, USA) for 1 h, washed again with PBS and prepared for confocal microscopy, as previously described. 43, 44 Flow cytometry
Transformants for fluorescence-activated cell sorting (FACS) analysis were processed as described in the immunofluorescence assay, except that all procedures were performed in 1.5 mL tubes. A FACS Calibur cytometer (Becton Dickinson, San Jose, CA, USA) was used to run and analyse the samples, as previously described. 45 Transcription and trifluoromethionine resistance in E. histolytica 377 
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Immunoprecipitation
Confluent cultures of EhBspA1-HA and pEhEx control transformants maintained with 20 mg/mL G418 were harvested by centrifugation at 500×g for 5 min. Cells were washed twice with cold PBS and 1 mL of lysis buffer [50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Triton-X 100, 5% glycerol, complete mini EDTA-free protease inhibitor cocktail (Roche Molecular Biochemicals, Mannheim, Germany) and 200 mM E-64] was added. Cell suspensions were subjected to three freeze-thaw cycles, followed by centrifugation at 12 000×g for 20 min. Protein (5 mg) was mixed with 50 mL of 50% anti-HA-agarose and incubated at 48C overnight with mild rotation. Agarose beads were collected by centrifugation at 500×g for 3 min and washed four times with 1 mL of lysis buffer at 48C with rotation for 10 min per wash. HA peptide (60 mL, 400 mg/mL) was added followed by incubation at room temperature for 2 h. Beads and eluate were collected by centrifugation and analysed by SDS-PAGE and immunoblot. Silver staining was performed with a Silver Stain MS Kit according to the manufacturer's instructions.
Results and discussion
Differentially expressed genes in TFMR
The emergence of drug resistance poses a significant obstacle to the success of chemotherapy. In parasitic protozoa, the mechanisms behind the development of resistance are not clearly understood and may arise from a plethora of genetic alterations during repeated exposure to a drug. Previously we have shown that in E. histolytica trifluoromethionine resistance results from EhMGL repression. 19 Complete gene inactivation, however, likely does not occur suddenly in situ, but develops progressively after continuous exposure to permissive concentrations of a drug. During this time, it is reasonable to assume that a number of processes occur concomitant with EhMGL repression.
To identify other potential genes associated with trifluoromethionine resistance, expression changes in TFMR were analysed by a whole-genome cDNA microarray. The relative ratio of mRNA abundance of 9230 genes ( 95% of all annotated amoebic genes) between TFMR and HM-1 was examined for differential expression. Only a limited number of genes showed 3-fold or higher changes in TFMR (63 probe sets; Figure 1 , Table S2 ). The list of genes was narrowed further to 35 (,1.0% of probe sets used) after the removal of redundant genes, probe sets labelled with '_x_at' and NCBI entries considered obsolete after standard genome annotation processing.
Twenty-three of the genes were upregulated, while 12 genes were downregulated (Tables 1 and 2 ). The most upregulated gene was a member of the leucine-rich repeat (LRR) protein family, designated EhBspA1 (EHI_015120) in this study, which was upregulated 527-fold. Genes encoding tyrosine kinase (EHI_070110), zinc finger protein (EHI_176800), and two hypothetical proteins (EHI_127670 and EHI_092110) were also upregulated by at least 25-fold. The most downregulated genes were EhMGL1 (EHI_144610) and EhMGL2 (EHI_142250), which had changes of 195-fold and 172-fold, respectively. An EF-hand calcium-binding domain-containing protein (EHI_151890) was also downregulated by more than 25-fold. These results support the idea that drug resistance requires the regulation and concerted action of a small number of amoeba proteins, and that genes other than EhMGL play roles, albeit not directly, in trifluoromethionine resistance.
Comparison with TFMR cultured without trifluoromethionine
Previously, we have shown that long-term culture of TFMR strains in the absence of trifluoromethionine, designated TFMR(2), failed to restore the susceptible phenotype. 19 To determine which of the modulated genes in TFMR were truly important in drug resistance, we compared its transcriptome with that of TFMR(2). We found the same genes to be differentially regulated, with the exception of the amino acid transporter (EHI_190460) and DnaJ family protein (EHI_183280), which were not significantly modulated in TFMR(2) (Figure 2b ). This is further evidence that genes listed in Tables 1 and 2 have definite roles in trifluoromethionine resistance. The return to steady-state levels of DnaJ and amino acid transporter, however, is understandable because removal of drug pressure is assumed to alleviate stress. It is possible that trifluoromethionine caused the repression of the promoters of these genes and that its removal caused the return of their expression to HM-1 levels. The possible roles of these two genes in trifluoromethionine resistance are discussed below. Currently, it is not known why more genes were modulated in TFMR(2) (Figure 2a) .
Confirmation of differential gene expression by qRT-PCR
Microarray results must be validated by an alternative and complementary gene expression profiling method, and qRT-PCR is the most commonly used technology for this purpose. (Figure 3b ). Penuliar et al.
Functional analysis
Based on GO annotations, the open reading frames (ORFs) of the identified genes encode proteins potentially involved in metabolism, signalling, vesicular trafficking and gene regulation (Table S3 ). Some genes, however, are without GO annotations, such as the two LRR BspA genes and a number of hypothetical proteins. While the GO annotations may be applicable for a variety of processes, genes in the same annotations may be the ones most essential in allowing cells to survive during the initial drug treatment. The functional significance of these changes and their relationship to the response to trifluoromethionine can only be explained by taking into account the relevant roles that they play in the control of key gene functions, such as metabolism and signal transduction. Very few of the differentially expressed genes encode potential membrane proteins. Only 9 (26%) of the genes contained 1 to 12 transmembrane domains (Table S4 ). Seven of these were upregulated while two were downregulated. Two genes presumably encode proteins with tyrosine kinase activity, while one encodes an amino acid transporter. Proteins encoded by five genes have predicted signal peptides (Table S4) , while two additional genes are predicted to encode proteins with signal Transcription and trifluoromethionine resistance in E. histolytica 379 JAC peptides but without transmembrane domains (chitinase, EHI_092100; hypothetical protein, EHI_117580). When we examined the genomic locations of these genes, we found that most of the genes were encoded on different scaffolds, while eight genes formed pairs that occupied the same contig (Table S5) . Two pairs, however, were located on opposite strands, but the members of each pair were regulated in the same manner. Fold changes for pairs found on the same strand were almost the same, while for those lying on opposite strands, the difference in fold changes was as high as 24. The distance between genes lying on the same strand was less than 640 bases; it was therefore possible for these genes to have the same regulatory elements.
Downregulation of EhMGL
EhMGL catalyses the single-step degradation of sulphurcontaining amino acids into ammonia, a-keto acids and volatile thiols such as methanethiol. 46 It has been implicated in the degradation of trifluoromethionine in E. histolytica, 15 and previously we have shown that EhMGL repression results in trifluoromethionine resistance. 19 The differential expression of EhMGL1 and EhMGL2 in this study confirms our previous report. While it is assumed that EhMGL may not be essential in amoebae growing in a nutrient-rich environment (which is why its repression was tolerated), its downregulation is not without consequences. It is possible that complete lack of EhMGL activity also leads to trifluoromethionine resistance indirectly through its role in metabolism and growth. Without EhMGL activity, TFMR strains lose one means of producing a-keto acids, i.e. pyruvate and butyrate, which are needed to form acetyl-CoA and a-propionic acid. Lower concentrations of these compounds would have an effect on energy production and growth. 47 While statistically comparable, the growth of TFMR strains is slightly slower than that of HM-1 as previously reported, and this growth defect is even more evident in the EhMGL genesilenced strains. 19 This slower growth hints at the importance of EhMGL, and, at the same time, may have been a survival strategy, as discussed below.
Overexpression of EhBspA1
E. histolytica encodes a family of BspA-like surface proteins composed of 75 members. 48 In bacteria, these proteins are expressed on the cell surface and promote adhesion to and invasion of epithelial cells. 49, 50 In this study, two EhBspA genes were upregulated in TFMR, one of which is not expressed in HM-1 (EHI_015120, designated EhBspA1 in this study) based on qRT -PCR and RT-PCR (Figure 3; Figure 4a ). We took this as an indication of its having an important role in trifluoromethionine resistance. To test this hypothesis, we created and characterized an EhBspA1 overexpresser and identified its effector molecule. The expression of EhBspA1 was confirmed by immunoblot against anti-HA antibody and qRT-PCR (Figure 4a and b) . Immunofluorescence assay of the EhBspA1 overexpressor showed that it is localized in the cytoplasm (Figure 4c ). This was verified by cell fractionation followed by immunoblot (data not shown). The results were consistent with its apparent lack of a transmembrane domain and signal peptide (Table S4) . It was therefore not surprising that overexpression of the gene did not increase the adhesive capacity of the transformant (Figure 4d ). In contrast, we previously showed that TFMR cells adhere more strongly than HM-1.
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EhBspA1 was partially resistant to trifluoromethionine compared with the pEhEx control (Figure 4e ). IC 50 values of the drug against the EhBspA1 overexpresser and the control were 25.1 mM and 13.8 mM, respectively. FACS analysis also showed that there was an increase, albeit low, in signal intensity when EhBspA1 was exposed to trifluoromethionine ( Figure S1a) . While the level of expression of EhBspA1 in BspA1-HA was significantly higher than with pEhEx-HA (Figure 4b) , the mRNA concentration we determined for TFMR was seven times greater ( Figure 3a) . It is conceivable that the low level of resistance in EhBspA1-HA compared with TFMR was partly due to the large difference in EhBspA1 expression. It should be noted, however, that the partial drug resistance and increased signal intensity observed in EhBspA1-HA was not due to a decrease in EhMGL activity, as was determined by immunoblot using anti-EhMGL antibody ( Figure S1b) .
A key feature of the BspA protein is a leucine-rich repeat (LRR) motif known to mediate protein -protein interactions. 51 The capacity of LRR proteins to interact with many ligands enables them to contribute to important cellular functions ranging from the regulation of the cell cycle to protein trafficking and signal transduction. 52 Through immunoprecipitation, we identified S-phase kinase-associated protein 1 (Skp1; EHI_134960) as the binding Penuliar et al.
protein of EhBspA1 ( Figure S1c ). In yeasts, Skp1 forms multiple protein complexes implicated in cell division, 53 induction of protective gene expression 54 and multidrug resistance. 55 It is possible that overexpression of EhBspA1 preceded the downregulation of EhMGL, and was important during the early stages of drug selection.
Genes involved in metabolism, stress and nucleic acid binding
The generation time of TFMR strains is longer than that of HM-1. 19 This phenotype may have resulted as a survival strategy through alterations in the activity of the metabolic genes listed in Tables 1 and 2 . In cancer cells it has been shown that growthstimulated cells are more susceptible to drugs because they have less time for DNA repair. 56, 57 A longer generation time would therefore be advantageous, as that would provide TFMR with the opportunity to prevent or repair damage, and may also allow more potent mechanisms of resistance to emerge over time. This may be the reason behind the downregulation of ribosomal protein S30 (EHI_088600) and sulfotransferase (EHI_031640), the latter of which has been shown to be important in the activation of a range of compounds. 58 The amino acid transporter (EHI_190460) identified in this study could be a potential transporter of trifluoromethionine. 14 It is possible that the gene was downregulated to prevent trifluoromethionine access to the cell, similarly to what has been seen in Trypanosoma brucei, where a loss of function in the amino acid transporter encoded by TbAAT6 resulted in eflornithine resistance. 5 DnaJ (EHI_183280) expression, on the other hand, is associated with enhanced susceptibility to chemotherapeutics in ovarian carcinoma, 59 which might account for its downregulation in TFMR.
The upregulation of chitinase (EHI_092100) might play a defensive role during the early stages of drug selection, similarly to S. cerevisiae, which protects itself from the toxin of Kluyveromyces lactis through its chitinase activity, possibly by binding to toxin or impairment of its uptake. 60 It was also reported that treatment of Candida albicans with chitinase resulted in increased resistance to amphotericin B. 61 The precise relationship of trifluoromethionine resistance and chitinase activity, however, remains to be demonstrated.
Several genes implicated in stress response were also modulated in TFMR. Glutamate synthase (EHI_045340; designated as NADPH-dependent oxidoreductase 2) belongs to the family of oxidoreductases, and in yeast its overexpression results in 
EHI_190460_at
Figure 2. Continued.
Transcription and trifluoromethionine resistance in E. histolytica 381 JAC resistance to methionine sulfoximine and tabtoxin. 62 In E. histolytica the enzyme plays an important role in redox maintenance, L-cysteine/L-cystine homeostasis, iron reduction and metronidazole activation. 63 Protein degradation mediated by Ulp1 (EHI_166820), on the other hand, is recognized to be critical in the regulation of the cell cycle, transcription and signal transduction. 64, 65 Its upregulation indicates that a ubiquitin-dependent proteolysis pathway was activated in response to trifluoromethionine, and suggests involvement of the ubiquitinproteasome system in drug resistance. The precise mechanism by which protein degradation may affect drug resistance remains to be determined. It is not clear how reduced proliferation occurs in the presence of these upregulated metabolic genes. It is likely that the effects of the repressed genes are more important and hence led to the reduced growth rate.
Two genes whose products bind nucleic acids were upregulated in TFMR. A zinc finger protein (EHI_176800) contains a DNA-binding domain and functions as part of transcription factor complex conferring DNA sequence specificity. In cancer cells resistant to anticancer drugs, its levels are increased, suggesting that it plays a role in cell survival. 66 Its overexpression in TFMR cells might be related to drug resistance, but identifying the relevant signalling mediators requires further investigation. DNA methyltransferase (EHI_121470), on the other hand, catalyses the transfer of a methyl group to DNA after replication, and epigenetically contributes to transcriptional regulation. 67 The increase in DNA methyltransferase expression in TFMR suggests that the differential expression of some of the proteins identified in this work is regulated by an epigenetic mechanism.
Comparative transcriptome analysis
To determine whether the transcriptome profile we observed was specific for TFMR, we compared it to those of the strains specifically targeted to silence EhMGL genes (EhMGL1gs and EhMGL2gs), the strain selected for reduced susceptibility to 8 mM metronidazole (MTZR) and the strain grown under cysteinedeprived conditions for 24 h [Cys(2)] (Figure 2a) . The results indicate that TFMR has a distinct signature profile (Figure 2b ). Comparison between TFMR and EhMGLgs showed that only EhMGL1 and EhMGL2 were commonly repressed in all three strains, except for a phosphatase domain-containing protein (EHI_085640), which was shared with EhMGL2gs. While all three strains were resistant to trifluoromethionine, the small number of genes they have in common indicates that the mechanism by which EhMGL repression occurred and the accompanying changes in gene expression, are clearly different between TFMR and EhMGLgs. It was also particularly striking that the upregulation of EhBspA1 occurred only in TFMR, confirming that it plays an important role in trifluoromethionine resistance.
Similarly, only four differentially expressed genes in TFMR were common to MTZR, and just two to Cys(2) (Figure 2b ). It should be noted, however, that while the fold changes in the gene Penuliar et al. Transcription and trifluoromethionine resistance in E. histolytica expression were comparable between the strains examined, their regulation was not always the same. Glutamate synthase (NADPH-dependent oxidoreductase) was upregulated in TFMR, while it was downregulated in MTZR and Cys (2) . Downregulation of the enzyme in MTZR was expected because glutamate synthase has been implicated in the activation of metronidazole in E. histolytica. 63 The lack of significant overlap between modulated genes in TFMR and MTZR was not surprising because the mode of action of trifluoromethionine and metronidazole is different. 6 -8,14 -17 Previously we showed that TFMR is not crossresistant to metronidazole. 19 Since MTZR only showed reduced susceptibility to metronidazole, it is unlikely that major mechanisms responsible for resistance were already established in the strain. TFMR and MTZR were therefore at different stages of resistance, but the modulated genes they have in common may play roles in stress response, which are often necessary in developing drug resistance. The specific regulation of genes in TFMR compared with Cys(2), on the other hand, indicates that the modulated genes in TFMR were not simply responses to stress but constitute a specific reaction towards developing resistance. Overall, differences in the profiles between strains illustrate that the transcriptional response of E. histolytica to trifluoromethionine is specific (Figure 2b ) and could be used as a signature profile of trifluoromethionine resistance.
Conclusion
The use of a DNA microarray has provided a genome-wide analysis of trifluoromethionine resistance in E. histolytica. We have shown that drug resistance is both multifactorial and specific, involving not just the repression of EhMGL, but the induction of EhBspA1 and the differential expression of a host of genes involved in metabolism, stress response and gene regulation. While the exact relationship between these genes is largely unknown, it is likely that, in vivo, these are the same changes necessary to initiate, support and extend trifluoromethionine resistance. If proven to be true, it will then be possible to design a PCR-based test to detect trifluoromethionine resistance in the future, allowing for more suitable treatments and improving the clinical outcome of chemotherapy.
